NOKOMIS, Fla.--(BUSINESS WIRE)--As emerging biotech firm Rainbow Coral Corp. (OTCBB: RBCC) closes in on a deal with a new clinical-stage company developing diagnostics and therapeutics for Parkinson’s disease, exciting news is emerging that drugs used to treat the disease could also be beneficial to patients suffering from traumatic brain injuries.
